Shares of Cantel Medical (NYSE:CMD) were flat in pre-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share decreased 70.91% over the past year to $0.16, which missed the estimate of $0.37.
Revenue of $236,933,000 rose by 3.67% from the same period last year, which missed the estimate of $242,630,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: Jun 04, 2020
Time: 08:30 AM
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/2203/34733
Technicals
52-week high: $93.87
52-week low: $20.81
Price action over last quarter: down 16.65%
Company Overview
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
